Jpmorgan Chase & CO Sanara Med Tech Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,786 shares of SMTI stock, worth $59,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,786
Previous 1,606
11.21%
Holding current value
$59,741
Previous $59,000
15.25%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SMTI
# of Institutions
40Shares Held
716KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$6.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$4.87 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA84.5KShares$2.83 Million0.0% of portfolio
-
State Street Corp Boston, MA53.8KShares$1.8 Million0.0% of portfolio
-
Janney Montgomery Scott LLC32.8KShares$1.1 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $278M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...